{"name": "Novexel",
 "permalink": "novexel",
 "crunchbase_url": "http://www.crunchbase.com/company/novexel",
 "homepage_url": "http://www.novexel.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2004,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "33 1 57 14 07 77",
 "description": "",
 "created_at": "Mon Dec 28 05:05:01 UTC 2009",
 "updated_at": "Mon Dec 28 05:05:01 UTC 2009",
 "overview": "\u003Cp\u003ENovexel SA, a pharmaceutical company, engages in the discovery and development of antibacterial and antifungal agents to treat bacterial and fungal infections. The company focuses on biology, medicinal chemistry, pharmacology, microbiology, and clinical development. It provides NXL201, an aminocandin anti-fungal agent; NXL104, an injectable beta-lactamase inhibitor to treat hospital infections that are caused by gram negative bacteria; NXL103, an oral streptogramin antibiotic to treat gram positive infections in the hospital setting and intravenous to oral switch; and NXL105, an anti-pseudomonal antibiotic. The company was founded in 2004 and is headquartered in Romainville, France.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       71],
      "assets/images/resized/0007/1317/71317v1-max-150x150.png"],
     [[217,
       104],
      "assets/images/resized/0007/1317/71317v1-max-250x250.png"],
     [[217,
       104],
      "assets/images/resized/0007/1317/71317v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Iain",
      "last_name": "Buchanan",
      "permalink": "iain-buchanan",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Gordon",
      "last_name": "Waldron",
      "permalink": "gordon-waldron",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 505000000.0,
   "price_currency_code": "USD",
   "term_code": "cash",
   "source_url": "http://www.fiercebiotech.com/press-releases/novexel-be-acquired-astrazeneca",
   "source_description": "Novexel to be Acquired by AstraZeneca",
   "acquired_year": 2009,
   "acquired_month": 12,
   "acquired_day": 23,
   "acquiring_company":
    {"name": "AstraZeneca",
     "permalink": "astrazeneca",
     "image":
      {"available_sizes":
        [[[150,
           37],
          "assets/images/resized/0006/4083/64083v1-max-150x150.png"],
         [[176,
           44],
          "assets/images/resized/0006/4083/64083v1-max-250x250.png"],
         [[176,
           44],
          "assets/images/resized/0006/4083/64083v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Parc Biocitech",
    "address2": "102, route de Noisy",
    "zip_code": "93230",
    "city": "Romainville",
    "state_code": null,
    "country_code": "FRA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0007/1316/71316v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0007/1316/71316v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0007/1316/71316v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}